Slide CordenPharma scientist in lab coat holding binder for News & Press header with white global connectivity background

NEWS & PRESS


All News & Press

March 25, 2021

Supporting mRNA Vaccines with Lipids for LNPs

Edition 1 / March 2021
Peptides, Lipids & Carbohydrates Platform > The Role of Lipids in mRNA Vaccine Production
March 25, 2021

Considerations for Safe Handling of HPAPIs

Edition 1 / March 2021
Highly Potent & Oncology Platform > Key Systematic & Scientific Elements to Safely Handle Your Highly Potent API
March 24, 2021

Nanos & CordenPharma Sign New Collaboration Agreement

March 24, 2021
News > CordenPharma and Nanos of South Korea sign a new collaboration agreement relating to the production of Peptides.
March 22, 2021

Highlights from 2020: CDMO Support for 100+ Projects, NCE Launches

Edition 1 / March 2021
2020 Highlights > Thank You to CordenPharma’s Dedicated Employees for an Unprecedented Year
January 22, 2021

CEO Magazine Interviews CordenPharma CEO & President Michael Quirmbach

Jan 22, 2021
CEO Magazine Interviews CordenPharma CEO & President Michael Quirmbach
December 14, 2020

Quality, Compliance & Continuous Supply
of Medicines

Edition 4 / December 2020
Editorial > How Quality & Compliance and Uninterrupted Supply of Essential Medicines Drives 2020
December 14, 2020

CordenPharma Chenôve Pandemic Safety Measures & Supply Chain

Edition 4 / December 2020
Editorial > CordenPharma Chenôve Ensures Safety Measures & Secure Supply Chain During COVID-19
December 14, 2020

Quality By Design For Pharma Development

Edition 4 / December 2020
Article > QRM & Knowledge Management As Key Enablers for QbD
December 14, 2020

Pandemic Shifts Focus to Digital Marketing Strategy

Edition 4 / December 2020
Article > A Marketing Year Like No Other: The Importance of Integrated Strategy
December 8, 2020

Eiger BioPharmaceuticals: FDA Approval of Zokinvy™ (Ionafarnib)

December 8, 2020
News > CordenPharma congratulates Eiger BioPharmaceuticals on their recent FDA Approval of Zokinvy (lonafarnib).
November 25, 2020

New GMP Peptide Expansion in Colorado

November 25, 2020
Press Release > CordenPharma Colorado Expands US GMP Peptide Manufacturing
November 17, 2020

Peptide Manufacturing Capacity Increasing in 2021

November 17, 2020
Press Release > CordenPharma Increases Centre of Excellence for Peptide Development Capacity.
November 16, 2020

Moderna Positive Phase 3 Results of mRNA-1273 Vaccine Candidate

November 16, 2020
News > CordenPharma Congratulates Moderna on positive Phase 3 results of mRNA-1273 COVID-19 vaccine.
October 23, 2020

Coronavirus Challenges & Opportunities

October 23, 2020
Article Interview > CHEManager Interviews Dr. Michael Quirmbach on the Coronavirus Opportunities for CDMOs
October 19, 2020

CordenPharma Colorado Completes Highly Potent API Expansion

October 19, 2020
Press Release > CordenPharma Colorado Completes Highly Potent API Laboratory Expansion